sur Aquis Stock Exchange
Aquis Stock Exchange: Trading Suspension Notice
On October 10, 2024, trading was suspended on the Aquis Growth Market for Mydecine Innovations Group Inc. This action was due to non-payment of exchange fees, in accordance with Rule 3.10 of the Aquis Stock Exchange Rulebook. The suspension affects the ordinary shares of the group.
The situation highlights the importance of compliance with trading rules and fee payments for companies listed on the exchange. The role of the Regulation Department at Aquis Stock Exchange is critical in enforcing these regulations to ensure market integrity.
The Aquis Stock Exchange continues to uphold its regulatory standards, emphasizing the need for all listed companies to adhere strictly to rules to avoid trading interruptions.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Aquis Stock Exchange